Effect of the Bamako-initiative drug revolving fund on availability and rational use of essential drugs in primary health care facilities in south-east Nigeria

Health Policy and Planning

Volumn 17, Issue 4, 2002, Pages 378-383

  Uzochukwu, Benjamin S C ^a,c   Onwujekwe, Obinna E ^a   Akpala, Cyril O ^a,b  

^a UNIVERSITY OF NIGERIA   (Nigeria)

^b Natl Prim Hlth Care Devmt Agency   (Nigeria)

^c Zone A Headquarters ^*  (Nigeria)

Author keywords

Bamako Initiative; Essential drugs; Nigeria; Prescribing practice; Primary health care; Rational use

Indexed keywords

ESSENTIAL DRUG;

ADULT; ARTICLE; CONSUMER; DRUG USE; FEMALE; HEALTH CARE FACILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NIGERIA; PATIENT COMPLIANCE; PATIENT COUNSELING; PRESCRIPTION; PRIMARY HEALTH CARE;

EID: 0036902661     PISSN: 02681080     EISSN: None     Source Type: Journal    
DOI: 10.1093/heapol/17.4.378     Document Type: Article

References (40)

1. Ait-Khaled N, Auregan G, Bencharif N et al. 2000. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. International Journal of Tuberculosis and Lung Disease 4: 268-71.
2. Ansah EK, Gyapong JO, Agyepong IA, Evans DB. 2001. Improving adherence to malaria treatment for children: The use of prepacked chloroquine tablets vs. chloroquine syrup. Tropical Medicine and International Health 6: 496-504.
3. Audibert M, Mathonnat J. 2000. Cost recovery in Mauritania: Initial lessons. Health Policy and Planning 15: 66-75.
4. Chabot J. 1988. The Bamako Initiative (letter). The Lancet 2: 1366-7.
5. CDC/WHO. Epi-Info 6.04 Software. Centers for Disease Control, Atlanta and World Health Organization, Geneva.
6. Falkenberg T, Nguyen TB, Larsson M, Nguyen TD, Tomson G. 2000. Pharmaceutical sector in transition - A cross sectional study in Vietnam. Southeast Asian Journal of Tropical Medicine and Public Health 31: 590-7.
7. Fasehun F. 1999. The antibacterial paradox: Essential drugs, effectiveness and cost. Bulletin of the World Health Organization 77: 211-16.
8. Federal Ministry of Health. 1990. Primary Health-Care Development Under the Bamako Initiative Strategy. 1990-1991 Project document. Abuja, Nigeria: Federal Ministry of Health.
9. Federal Ministry of Health. 1994. The Bamako Initiative Programme in Nigeria. Abuja, Nigeria: Federal Ministry of Health, Bamako Initiative Unit.
10. Federal Ministry of Health. 1996. Essential Drug List for Use at Health Centres. Abuja, Nigeria: Federal Ministry of Health, Bamako Initiative Unit.
11. Garner P. 1989. The Bamako Initiative: Financing health in Africa by selling drugs. British Medical Journal 299: 277-8.
12. Garraoui A, Le-Feuvre P, Ledoux M. 1999. Introducing management principles into the supply and distribution of medicines in Tunisia. Bulletin of the World Health Organization 77: 525-9.
13. Gilson L, Jaffar S, Mwankusye S, Teuscher T. 1993. Assessing Prescribing Practices: A Tanzanian example. International Journal of Health Planning and Management 8: 37-58.
14. Greenhalgh T. 1987. Drug prescriptions and self-medication in India, an exploratory survey. Social Science and Medicine 25: 307-18.
15. Hardon AP. 1987. The use of modern pharmaceuticals on a Filipino village doctors' prescriptions and self-medication. Social Science and Medicine 25: 277-92.
16. Hogerzeil HV, Ross Degnan R, Laing R et al. 1995. Field-tests for rational drug use in twelve developing countries. The Lancet 342: 1409-10.
17. Kanji N. 1989. Charging for drugs in Africa: UNICEF's "Bamako Initiative". Health Policy and Planning 4:110-20.
18. Kshirsagar MJ, Langade D, Patil S, Patki PS. 1998. Prescribing patterns among medical practitioners in Pune India. Bulletin of the World Health Organization 76: 271-5.
19. Laing R. 1990. Rational drug use: An unsolved problem. Tropical Doctor 20: 101-3.
20. Laing R, Hogerzeil H, Ross Degnan D. 2001. Ten recommendations to improve drug use. Health Policy and Planning 16: 13-20.
21. The Lancet. 1988. The Bamako Initiative, Editorial. The Lancet 2: 1177-8.
22. Litvack J, Bodart C. 1993. User fees plus quality equals improved access to health care; results of a field experiment in Cameroon. Social Science and Medicine 37: 369-83.
23. McPake B, Hanson K, Mills A. 1993. Community Financing of Health Care in Africa. An evaluation of the Bamako Initiative Programme. Social Science and Medicine 36: 1383-95.
24. Michel JM. 1985. Why do people like Medicines? A perspective from Africa. The Lancet 26: 210-11.
25. Mynika KS, Killewo JZJ. 1991. Irrational drug use in Tanzania. Health Policy and Planning 6:180-4.
26. Ndyomugyeni R, Neema S, Magnussen P. 1998. The use of formal and informal services for antenatal care and malaria treatment in rural Uganda. Health Policy and Planning 13: 94-102.
27. Nes SA. 1990. Principles of therapeutics. In: Gilman GA, Rali NT (eds). The Pharmacological Basis of Therapeutics. New York: Pergoman Press, pp. 62-83.
28. Nichter M. 1989. Pharmaceuticals, health modification and social relations: Ramifications for primary health care. In: Nichter M. Anthropology and International Health: South Asian Case Studies. Dordrecht/Boston/London: Kluwer, Academic Publishers.
29. Ogunbekun I, Adeyi O, Wouters A Morrow R. 1996. Cost and Financing of improvements in the quality of material health services through the Bamako Initiative in Nigeria. Health Policy and Planning 11: 369-84.
30. Ogundeji MO. 1997. Practical experience in support, supervision and monitoring of BI in Nigeria - The case of FMOH/NPHCDA Health Zone B. Conference Paper on Bamako Initiative. Abuja, Nigeria: Federal Ministry of Health.
31. Okonkwo PO, Akpala CO, Okafor HU, Mbah AU, Nwaiwu O. 2001. Compliance to correct dose of chloroquine in uncomplicated malaria correlates with improvement in the condition of rural Nigerian children. Transactions of the Royal Society of Tropical Medicine and Hygiene 95: 320-4.
32. Pecoul B, Chirac P, Trouiller P, Pinel J. 1999. Access to essential drugs in poor countries: A lost battle? Journal of the American Medical Association 281: 361-7.
33. Reeler AV. 1990. Injections: A fatal attraction. Social Science and Medicine 31: 1119-25.
34. Salako L. 1998. Artemisinin and its derivatives: The regulatory and policy implications for African countries. Medecine Tropicale (Mars) 58: 82-4.
35. Soumerai SB, Ross-Degnan D. 1999. Inadequate drug coverage in medicine: A call to action. New England Journal of Medicine 340: 722-8.
36. WHO. 1993a. How to Investigate Drug Use in Health Facilities Selected Drug Use Indicators. Action Programme on Essential Drugs. Geneva: World Health Organization.
37. WHO. 1993b. The Work of WHO in the African Region, 1991 to 1992. AFR/RC43/3. Harare: World Health Organization.
38. World Bank. 1992. Pharmaceutical Expenditures and Cost Recovery Schemes in Sub-Saharan Africa. Technical working paper 4. Africa Technical Department, Population, Health, and Nutrition Division. Washington, DC: World Bank.
39. World Bank. 1994. The importance of pharmaceuticals and essential drug programmes. In: Better Health in Africa Experience and Lessons Learned. Washington DC: World Bank.
40. Wyatt HG. 1984. The popularity of injections in the third world: Origins and consequences for Poliomyelitis. Social Science and Medicine 19: 911-15.